Chemoinformaics analysis of 5,7-DIHYDROXY-3,6,8-TRIMETHOXYFLAVONE
| Molecular Weight | 344.319 | nRot | 4 |
| Heavy Atom Molecular Weight | 328.191 | nRig | 18 |
| Exact Molecular Weight | 344.09 | nRing | 3 |
| Solubility: LogS | -4.191 | nHRing | 1 |
| Solubility: LogP | 2.89 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 46.3427 |
| nHD | 2 | BPOL | 23.8633 |
| QED | 0.751 |
| Synth | 2.479 |
| Natural Product Likeliness | 1.313 |
| NR-PPAR-gamma | 0.819 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 1 |
| Pgp-sub | 0 |
| HIA | 0.023 |
| CACO-2 | -4.867 |
| MDCK | 0.0000223 |
| BBB | 0.009 |
| PPB | 0.866753 |
| VDSS | 0.858 |
| FU | 0.163058 |
| CYP1A2-inh | 0.709 |
| CYP1A2-sub | 0.969 |
| CYP2c19-inh | 0.278 |
| CYP2c19-sub | 0.455 |
| CYP2c9-inh | 0.831 |
| CYP2c9-sub | 0.805 |
| CYP2d6-inh | 0.068 |
| CYP2d6-sub | 0.246 |
| CYP3a4-inh | 0.332 |
| CYP3a4-sub | 0.226 |
| CL | 1.77 |
| T12 | 0.771 |
| hERG | 0.099 |
| Ames | 0.494 |
| ROA | 0.498 |
| SkinSen | 0.643 |
| Carcinogencity | 0.132 |
| EI | 0.678 |
| Respiratory | 0.089 |
| NR-Aromatase | 0.917 |
| Antiviral | Yes |
| Prediction | 0.844931 |